|
|
|
Insider
Information: |
Caldwell William S |
Relationship: |
SVP - Drug Discovery a... |
City: |
Winston-Salem |
State: |
NC |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
6,735 |
|
Indirect Shares
|
2,500 |
|
|
Direct
Value |
$3,444 |
|
|
Indirect Value
|
$1,278 |
|
|
Total
Shares |
9,235 |
|
|
Total
Value |
$4,722 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Gyre Therapeutics |
GYRE |
SVP - Drug Discovery a... |
2011-09-20 |
6,735 |
2011-09-20 |
2,500 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
53 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GYRE |
Gyre Therapeutics |
VP - Drug Discovery and Dev. |
|
2009-08-11 |
4 |
OE |
$1.75 |
$17,287 |
D/D |
6,780 |
14,515 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
VP - Drug Discovery and Dev. |
|
2009-08-11 |
4 |
S |
$12.69 |
$86,023 |
D/D |
(6,780) |
7,735 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
SVP - Drug Discovery and Dev. |
|
2011-03-01 |
4 |
OE |
$8.51 |
$96,674 |
D/D |
11,360 |
19,095 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
SVP - Drug Discovery and Dev. |
|
2011-03-01 |
4 |
S |
$30.00 |
$340,800 |
D/D |
(11,360) |
7,735 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
SVP - Drug Discovery and Dev. |
|
2010-12-13 |
4 |
S |
$23.95 |
$287,377 |
D/D |
(12,000) |
7,735 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
SVP - Drug Discovery and Dev. |
|
2010-12-13 |
4 |
OE |
$1.75 |
$21,000 |
D/D |
12,000 |
19,735 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
VP - Drug Discovery and Dev. |
|
2009-08-31 |
4 |
OE |
$1.75 |
$24,421 |
D/D |
13,955 |
21,690 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
VP - Drug Discovery and Dev. |
|
2009-08-31 |
4 |
S |
$14.54 |
$202,881 |
D/D |
(13,955) |
7,735 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
SVP - Drug Discovery and Dev. |
|
2010-04-30 |
4 |
OE |
$5.55 |
$84,710 |
D/D |
15,263 |
22,998 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
SVP - Drug Discovery and Dev. |
|
2010-04-30 |
4 |
S |
$24.27 |
$370,506 |
D/D |
(15,263) |
7,735 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
SVP - Drug Discovery and Dev. |
|
2011-02-28 |
4 |
S |
$28.00 |
$433,468 |
D/D |
(15,481) |
7,735 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
SVP - Drug Discovery and Dev. |
|
2011-02-28 |
4 |
OE |
$5.55 |
$85,920 |
D/D |
15,481 |
23,216 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
SVP - Drug Discovery and Dev. |
|
2010-04-20 |
4 |
S |
$23.00 |
$365,700 |
D/D |
(15,900) |
7,735 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
SVP - Drug Discovery and Dev. |
|
2010-04-20 |
4 |
OE |
$5.10 |
$84,985 |
D/D |
15,900 |
23,635 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
SVP - Drug Discovery and Dev. |
|
2010-04-28 |
4 |
OE |
$1.75 |
$28,000 |
D/D |
16,000 |
23,735 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
SVP - Drug Discovery and Dev. |
|
2010-04-28 |
4 |
S |
$24.00 |
$384,000 |
D/D |
(16,000) |
7,735 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
SVP - Drug Discovery and Dev. |
|
2011-02-16 |
4 |
OE |
$1.75 |
$29,146 |
D/D |
16,655 |
24,390 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
SVP - Drug Discovery and Dev. |
|
2011-02-16 |
4 |
AS |
$26.52 |
$441,656 |
D/D |
(16,655) |
7,735 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
SVP - Drug Discovery and Dev. |
|
2010-05-03 |
4 |
OE |
$5.55 |
$136,613 |
D/D |
17,000 |
24,735 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
SVP - Drug Discovery and Dev. |
|
2010-05-03 |
4 |
S |
$24.29 |
$412,848 |
D/D |
(17,000) |
7,735 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
VP - Drug Discovery and Dev. |
|
2009-12-16 |
4 |
OE |
$3.53 |
$81,784 |
D/D |
23,201 |
30,936 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
VP - Drug Discovery and Dev. |
|
2009-12-16 |
4 |
S |
$21.93 |
$508,868 |
D/D |
(23,201) |
7,735 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
VP - Drug Discovery and Dev. |
|
2009-12-16 |
4/A |
S |
$21.93 |
$508,977 |
D/D |
(23,206) |
7,735 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
VP - Drug Discovery and Dev. |
|
2009-12-16 |
4/A |
OE |
$3.53 |
$81,801 |
D/D |
23,206 |
30,941 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
SVP - Drug Discovery and Dev. |
|
2010-04-29 |
4 |
OE |
$1.75 |
$145,082 |
D/D |
35,100 |
42,835 |
0 |
- |
|
53 Records found
|
|
Page 2 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|